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Abstract
Background: The Major Depression Inventory (MDI) is a new, brief, self-report measure for
depression based on the DSM-system, which allows clinicians to assess the presence of a depressive
disorder according to the DSM-IV, but also to assess the severity of the depressive symptoms.
Methods: We examined the sensitivity, specificity, and psychometric qualities of the MDI in a
consecutive sample of 258 psychiatric outpatients. Of these patients, 120 had a mood disorder (70
major depression, 49 dysthymia). A total of 139 subjects had a comorbid axis-I diagnosis, and 91
subjects had a comorbid personality disorder.
Results: Crohnbach's alpha of the MDI was a satisfactory 0.89, and the correlation between the
MDI and the depression subscale of the SCL-90 was 0.79 (p < .001). Subjects with major depressive
disorder (MDD) had a significantly higher MDI score than subjects with anxiety disorders (but no
MDD), dysthymias, bipolar, psychotic, other neurotic disorders, and subjects with relational
problems. In ROC analysis we found that the area under the curve was 0.68 for the MDI. A good
cut-off point for the MDI seems to be 26, with a sensitivity of 0.66, and a specificity of 0.63. The
indication of the presence of MDD based on the MDI had a moderate agreement with the diagnosis
made by a psychiatrist (kappa: 0.26).
Conclusion: The MDI is an attractive, brief depression inventory, which seems to be a reliable
tool for assessing depression in psychiatric outpatients.
Background
Most rating scales which measure the presence and sever-
ity of depressive symptoms were developed before the
release of the evidence-based diagnostic system DSM-III
in 1980 [1,2]. Therefore, the items of these scales are not
based on the DSM system, and may not be the optimal
way of measuring major depression. One way to solve this
problem is to modify the older instruments and adapt to
the modern concept of depressive disorder, as has been
done with the 40-year old Hamilton Depression Scale
(HAM-D) [3], and the equally old BDI [4,5]. Another way
to solve this problem is by developing new instruments,
which cover DSM and ICD items better. Several of these
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as the IDS and QIDS [6], and the PHQ-9 [7].
One other self-report measure for depression which is
based on the DSM-system is the Major Depression Inven-
tory (MDI). The MDI includes all symptoms of depression
in the DSM-IV and the ICD-10. Each of these symptoms is
rated on a six-point scale, which allows clinicians to assess
the presence of a depressive disorder according to the
DSM-IV and the ICD-10 (each symptom is dichot-
omized), but also to assess the severity of the depressive
symptoms (by summing up the scores of all symptoms,
with a range of 0 to 50). The MDI is attractive because it is
brief, it allows clinicians to assess the presence of a depres-
sive disorder, and it can be filled in by the patient himself.
Research examining the psychometric qualities of the
MDI is limited. Earlier studies have evaluated the applica-
bility and internal validity of the MDI [8], the sensitivity
and specificity in psychiatric outpatients [2], and the psy-
chometric properties in general [9]. The results of these
studies indicate that the MDI has good sensitivity, specif-
icity, reliability and validity. Because the number of stud-
ies is limited and because these studies are conducted in
relatively small samples, more research is needed to con-
firm the positive results of earlier research. Furthermore,
for diagnostic classification, studies with mixed groups of
outpatients are needed to confirm the validity and appli-
cability of the scale.
In the current study, we will examine the sensitivity, spe-
cificity, and psychometric qualities of the MDI in a natu-
ralistic investigation including 258 outpatients in mental
health care.
Methods
Subjects and procedure
Subjects were patients who sought help for mental disor-
ders at a large outpatient clinic ("Roeterstraat") of Men-
trum Mental Health Care in Amsterdam. Data were
collected in a routine intake procedure of this outpatient
clinic, in which patients were asked to fill in several instru-
ments for the purpose of diagnostic assessment of the per-
sonality and therapy indication. Conforming to current
legal requirements and with approval of a medical ethical
committee (full name of the committee is: "METIGG;
Stichting Medisch-Ethische Toetsingscommissie Instel-
lingen Geestelijke Gezondheidszorg"), patients were
informed that these anonimised routine clinical data may
be used for the purpose of a scientific assessment study. If
the patient did not want that their data were used for
research purposes, the patient could report this to the
research coordinator and in such a case the data were not
used.
Mental disorders were assessed according to the DSM-IV
criteria by six experienced psychiatrists in a regular diag-
nostic interview. These psychiatrists had three-weekly
consensus meetings during which they discussed the diag-
noses of the included patients. In keeping with current
Dutch legal requirements, patients were informed that
anonimised routine clinical data might be used for the
purpose of research and given the choice to "opt out", in
which case their data were not used.
A consecutive sample of 465 subjects was used for this
study. Of these 465 subjects, 99 were not assigned a diag-
nosis during the intake phase (because they did not show
up at their first appointment at the outpatient clinic, or
dropped out during the intake phase) and were removed
from the dataset. Of the remaining 366 subjects, 108 did
not fill in the MDI (N = 90) or not completely (N = 18),
mainly because of language problems. Of the remaining
258 subjects with an MDI, 208 had an SCL-D score, and
229 had an SCL-A score.
Selected characteristics of the resulting sample of 258 sub-
jects are presented in Table 1. Almost half of the subjects
were male, most had a higher education, and were
younger than 40 years of age.
Table 1: Selected characteristics of the included sample 
outpatients in mental health care (N = 258)
N %
Gender Male 111 43.0
Female 142 55.0
Missing 5 1.9
Education Lower 16 6.2
Higher 106 41.1
Unknown 136 52.7
Age < 40 years 171 66.3
≥ 40 years 86 33.3
Missing 1 0.4
M (SD) 36.45 (10.13)
Primary diagnosis Mood disorder 102 39.5
- MDD 63 24.4
- Dysthymia 33 12.8
- Other mooda) 6 2.3
Bipolar disorder 10 3.9
Anxiety disorder 41 15.9
Psychotic disorder 12 4.7
Other neurotic disorder 36 36
Relational problems 25 9.7
Substance use disorder 16 6.2
Otherb) 16 6.2
a) depressive disorder caused by a somatic illness (N = 1), or a 
depressive disorder Not Otherwise Specified (N = 7).
b) other disorders are specified in the textPage 2 of 6
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orders (major depression (293.83, 296.2x, 296.3x), dys-
thymia (300.4) and depression Not Otherwise Specified
(311, 296.90)), anxiety disorders (phobic disorders, panic
disorder, generalized anxiety and obsessive-compulsive
disorder (300.0x, 300.1, 300.2x, 308.3, 309.81)), bipolar
disorder (296.0x, 296.4x, 296.5x, 296.6x, 296.7, 296.8x,
301.13), schizophrenia and other psychotic disorders
(293, 293.81, 293.82, 295.xx, 297.xx, 298.xx), other neu-
rotic disorders (300.11–15, 300.6, 300.7, 300.81, 307.8x,
309.0, 309.24, 309.28, 309.3, 309.4, 309.9), relational
problems (V61.xx, V62.xx, V71.01, V71.02, V15.81,
V65.2, 780.9, 313.82), substance use disorder (291.xx,
292.xx, 303.xx, 305.xx) and other disorders (all the other
codes grouped).
As can be seen in Table 1, most subjects had a mood dis-
order, anxiety disorder, or another neurotic disorder as
the primary DSM-IV diagnosis. Apart from the primary
diagnosis, 139 subjects had a secondary DSM-IV axis-I
diagnosis. A total of 91 subjects also had a personality dis-
order.
One hundred and twenty subjects (46.5%) had a mood
disorder (as the first or second diagnosis; Table 2). Of
these 120 subjects, 70 had a major depressive disorder,
while 49 had dysthymia. Eight subjects had another
depressive disorder (in one case caused by somatic illness,
in the other cases it was a depressive disorder Not Other-
wise Specified).
Measures
Major Depression Inventory (MDI). The MDI is a 12-item
self-report questionnaire for depression, intended to
measure DSM-IV diagnosis of major depression by the
patients' self-reported symptoms. The items of the MDI
ask the patient to rate how much time in the past two
weeks each of the symptoms of the depressive syndrome
was present (on a six-point rating scale ranging from none
to all of the time). As indicated earlier, the MDI can be
used to get an indication of the presence of major depres-
sion (according to the algorithm of the DSM-IV), or as an
instrument measuring severity of depression (with a range
of 0 to 60).
We used the Dutch translation of the MDI. The translation
and back translation of the MDI was made by two of the
authors (PC and JD); one of whom did the translation
and the other who did not know the original English text,
did the back translation. The final translation was fixed by
consensus.
Symptom Checklist (SCL-90) – depression subscale and
anxiety subscale. Depressive symptomatology was also
assessed with the Depression Scale of the Symptom Check
List – 90, Dutch version [10]. This self-report scale meas-
ures the severity of symptoms and consists of 16 psycho-
logical symptoms which must be rated on a 5-point scale,
ranging from 1 (not distressed by the symptom) to 5
(extremely distressed by the symptom). A total score can
be obtained by adding the item scores, ranging from 16
(no depressive symptomatology) to 80 (high level of
depressive symptoms). The anxiety subscale of the SCL-90
consists of 10 items indicating the degree to which a per-
son had symptoms of anxiety in the past week (range 10
to 50). The SCL-90 is a much used instrument with excel-
lent psychometric properties [10].
Table 2: Means and standard deviation at the MDI in psychiatric outpatients
All Men Women
N M SDc) N M SDc) N M SDc)
Mood disorder 120 27.69 10.60 *** 54 27.57 9.46 ** 63 27.33 11.54 **
- MDD 70 29.96 9.97 *** 29 29.10 8.89 ** 40 30.30 10.75 ***
- Dysthymia 49 25.80 11.65 24 25.08 10.62 22 25.00 12.75
- Other mooda) 8 21.88 8.87 3 25.00 4.58 5 20.00 10.75
Bipolar disorder 11 15.64 11.84 * 9 11.33 7.73 *** 2 35.00 2.83
Anxiety disorder 59 24.32 11.84 23 28.61 9.16 * 35 22.03 12.53
Psychotic disorder 12 19.50 11.81 10 21.10 12.20 2 11.50 6.36
Other neurotic disorder 43 23.33 11.86 15 23.33 8.80 27 23.26 13.62
Relational problems 62 21.11 12.31 * 21 19.52 11.47 * 41 21.93 12.78
Substance use disorder 44 26.52 11.84 30 25.57 11.79 13 27.62 12.06
Otherb) 26 21.35 12.94 7 25.57 12.90 19 19.79 12.95
Total population 258 24.03 12.12 111 23.99 11.17 142 23.91 12.79
***: p < .001; **: p < .01; *: p < .05; ns: not significant
a) depressive disorder caused by a somatic illness (N = 1), or a depressive disorder Not Otherwise Specified (N = 7).
b) other disorders are specified in the text
c) p-values indicate whether the mean MDI-scores in the diagnostic category differ significantly from the rest of the population, as tested with T-
tests.Page 3 of 6
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ders of patients were assessed according to the DSM-IV cri-
teria by experienced psychiatrists in a regular diagnostic
interview.
Analyses
In the first part of the analyses, we examined the MDI as a
measure indicating the severity of the depressive symp-
tomatology.
First, we calculated the reliability of the MDI (Cronbachs
alpha). We also calculated the correlation with the SCL-90
depression subscale. A high correlation supports the con-
struct validity of the MDI.
Then we calculated the means and standard deviations
(SDs) of the MDI in all diagnostic categories (major
depression; dysthymia; anxiety disorder; psychotic disor-
der; and other). We furthermore calculated means and
SDs separately for men and women. We subsequently
examined with t-tests whether the mean MDI score dif-
fered in subjects with major depression compared to sub-
jects with other diagnoses. Significantly higher MDI-
scores in subjects with major depression can be seen as an
indication that the MDI actually is a measure of depres-
sion.
We also calculated the sensitivity and specificity of differ-
ent cut-off values at the MDI in detecting major depres-
sion and dysthymia, and performed Receiver Operating
Characteristic (ROC) analyses. We also performed ROC
analyses for the SCL-90-D, and we tested the equality of
the MDI and the SCL-90-D.
In the second part of the analyses, we concentrated on the
MDI as an instrument which gives an indication of the
presence of MDD, and compared it to the MDD diagnosis
as given by the psychiatrist. We calculated the sensitivity
and specificity of the MDI-indication of a DSM-IV diagno-
sis of major depression, in different subpopulations. In
these analyses, we calculated the kappa statistic as an indi-
cation of the agreement between the judgment of the psy-
chiatrist and the MDI.
The t-tests, reliability analyses, correlations, and the calcu-
lations of the sensitivity, specificity, and kappa statistic
were conducted in SPSS 12.0.02; the ROC analyses were
conducted in STATA/SE 8.2 (which permits testing of the
equality of two different measures given a gold standard).
Results
The MDI as a measure of severity
The reliability of the MDI, as indicated with Crohnbachs
alpha was a satisfactory 0.89.
The correlation between the scores of the MDI and the
depression subscale of the SCL was 0.79 (p < .001), and
between the MDI and the anxiety subscale of the SCL 0.57
(p < .001).
The means and SD on the MDI for the different diagnostic
categories are presented in Table 2. Subjects with a mood
disorder had a significantly higher MDI-score than the rest
of our sample (p < .001), and this was true for men (p <
.001) and for women (p < .01). When we differentiated
among the subjects with a mood disorder, we found that
subjects with MDD had a significantly increased MDI-
score (p < .001), but subjects with dysthymia or another
depressive disorder did not have a significantly increased
score. Subjects with a bipolar disorder and those with rela-
tional problems had a significantly lower MDI score than
the other subjects (p < .05). Men with a bipolar disorder
(p < .001) or relational problems had a lower MDI score
than other subjects (p < .05), while men with an anxiety
disorder had an increased MDI score (p < .05).
Then we compared the mean MDI score in subjects with a
major depressive disorder (but no anxiety disorder) to the
MDI in subjects with an anxiety disorder (but not a
comorbid major depressive disorder). Those with MDD
had a significantly higher MDI score (M = 29.64; SD =
10.63; N = 59) than those with an anxiety disorder (M =
22.65; SD = 12.31; N = 48; p < .01)). In the same way, we
compared subjects with MDD to subjects with dysthymia,
with another depressive disorder, with a bipolar disorder,
with a psychotic disorder, with another neurotic disorder,
with relational problems, and with a substance use disor-
der. The subjects with dysthymia (M = 24.76; SD = 11.08;
N = 41; p < .05) differed significantly from those with
MDD (p < .01), as did those with another depressive dis-
order (M = 21.89; SD = 8.87; N = 8; p < .05), a bipolar dis-
order (M = 15.64; SD = 11.84; N = 11; p < .001), a
psychotic disorder (M = 19.50; SD = 11.81; N = 12; p <
.01), another neurotic disorder (M = 23.35; SD = 12.14; N
= 40; p < .01), and those with relational problems (M =
19.28; SD = 11.63; N = 54; p < .001). There was a trend
indicating a difference between the MDI score in those
with MDD and those with a substance use disorder (M =
25.03; SD = 11.88; N = 38; p < .1).
Among the subjects with MDD, we examined whether
there was a relationship between the MDI-score and
demographic variables (gender, age, and education). We
found no association between the MDI-score on the one
hand, and gender and education on the other hand. How-
ever, we did find a significant correlation between MDI
and age (r = 0.24; p < 0.05), indicating a somewhat higher
MDI with increasing age.Page 4 of 6
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ROC analysis in which we compared the MDI to the SCL-
90 depression scale. The area under the curve was 0.68 for
the MDI, which was about the same as the area under the
curve for the SCL-D (0.67; non-significant difference; p =
0.73). The sensitivity, specificity, and percentage correctly
classified is presented in Table 3, and the ROC curve is
presented in Figure 1.
The MDI as an indicator of MDD
We calculated the sensitivity and specificity of the indica-
tion of the presence of MDD based on the MDI (MDI-
MDD) compared to the judgment of the psychiatrist (the
gold standard). The sensitivity was 65.71, while the specif-
icity was 64.89. We also calculated the kappa statistic as an
indicator of the agreement between the two judgments.
This was found to be 0.26, which according to the bench-
marks from Landis and Koch [11] was moderate.
We compared the MDI-MDD in several subpopulations.
In these analyses we selected the subjects with a specific
diagnosis (while excluding the subjects with that diagno-
sis and a comorbid MDD), and compared these to the
subjects with MDD (while excluding the subjects with
MDD and the comorbid diagnosis). In this way, we com-
pared subjects with an anxiety disorder (but no MDD) to
subjects with MDD (but no anxiety disorder). The kappa
of the MDI-MDD and the judgment of the psychiatrist was
a moderate 0.25. In the same way, we compared subjects
with MDD to subjects with dysthymia, with other mood
disorder, with a bipolar disorder, with a psychotic disor-
der, with another neurotic disorder, with relational prob-
lems, with a substance use disorder, and with another
disorder. In all cases, a moderate kappa (0.19–0.35) was
found, indicating only a modest ability of the MDI to dif-
ferentiate between subjects with MDD and other mental
disorders in this population.
Discussions and Conclusion
To our knowledge, this study is the first in which the psy-
chometric characteristics of MDI are examined in different
diagnostic categories of psychiatric outpatients. With a
good reliability, a strong correlation with another meas-
ure of depressive symptomatology, and acceptable sensi-
tivity and specificity, the MDI seems to be a useful and
valuable new instrument for assessing depression in psy-
chiatric outpatients.
One of the strong points of the MDI is that it can be used
in two ways. First, it can be used as a continuous scale
which indicates the level of depressive symptomatology.
And second, it has an algorithm that allows clinicians to
get an indication of the presence of MDD according to
diagnostic criteria. However, our results show that the
algorithm does not result in a higher sensitivity or specif-
icity than a cut-off point on the MDI as a severity scale.
This confirms the results of research in the general popu-
lation, which also found that the MDI score rather than
the MDI definition of major depression should be used in
population based research [12].
In earlier reports on the MDI, a cut-off point of 26 was
found for the MDI [2,12]. This cut-off point was sup-
ported by our study, with a sensitivity of 0.66, and a spe-
cificity of 0.63. This was much lower than in other studies
Receiver Operating Characteristic (ROC) analyses, with the MDI and the SCL-90-D, using the diagnosis of MDD as gold stand r 1)Figure 1
Receiver Operating Characteristic (ROC) analyses, with the 
MDI and the SCL-90-D, using the diagnosis of MDD as gold 
standard 1). 1) Mental disorders were assessed according to 
the DSM-IV criteria by experienced psychiatrists in a regular 
diagnostic interview.
Table 3: Sensitivity (%) and specificity (%) of the Major 
Depression Inventory compared to DSM-diagnoses at different 
cut-off points (N = 228)
Cut-off Sensitivity Specificity
≥ 19 85.71 43.62
≥ 20 85.71 45.21
≥ 21 85.71 47.34
≥ 22 82.86 49.47
≥ 23 78.57 51.06
≥ 24 77.14 53.19
≥ 25 74.29 56.91
≥ 26 71.43 59.57
≥ 27 65.71 62.77
≥ 28 58.57 64.36
≥ 29 55.71 68.62
≥ 30 55.71 70.21
≥ 31 52.86 75.53
≥ 32 48.57 77.66
≥ 33 47.14 79.79
≥ 34 41.43 81.91
≥ 35 38.57 84.04Page 5 of 6
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of the MDI in clinical populations (with a sensitivity of
1.00 and a specificity of 0.82; [2]; and a sensitivity of 0.86
and a specificity of 0.94; [9]), but resembled the results of
a study in the general population (sensitivity 0.61 and
specificity 0.85, [12]).
This study has several limitations. First, no standardized
instrument, such as the SCAN or the CIDI was used to
assess the presence of mental disorders. In our study, the
standard assessment by psychiatrists in routine practice
was used as the gold standard. We did not assess inter rater
reliability. This procedure may have resulted in an under-
estimation of the number of subjects with major depres-
sion, which in turn may have resulted in a reduced ability
to differentiate subjects with major depression from those
without. Second, most patients in our sample had more
than one (Axis-I or Axis-II) disorder and this comorbidity
may have distorted the results of our study. On the other
hand, this high level of comorbidity reflects the actual
complexity of patients seeking help in outpatient mental
health care, and if this limits the results of the MDI, this
should be seen as an indication that the MDI may not be
used in this population. Third, the number of subjects in
the different diagnostic categories was relatively small,
which resulted in low power to detect differential effects.
Because of these limitations, the results of this study have
to be interpreted with caution.
The MDI is an attractive, brief depression inventory,
which seems to be a reliable tool for assessing depression
in psychiatric outpatients. More research with large sam-
ples and standardized diagnostic interviews is clearly war-
ranted. Furthermore, an indication of the impairment
criterion would most likely improve the specificity.
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